New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Could gut fungi be linked to severe COVID? What to make of new research findings

Could gut fungi be linked to severe COVID? What to make of new research findings

Could gut fungi be linked to severe COVID? What to make of new research findingsby Paul Griffin,The ConversationCredit: CC0 Public DomainMany tiny organisms including bacteria, fungi and viruses
Gastroenterology January 24,2024
Could gut fungi be linked to severe COVID? What to make of new research findings

Could gut fungi be linked to severe COVID? What to make of new research findings

Could gut fungi be linked to severe COVID? What to make of new research findingsby Paul Griffin,The ConversationCredit: CC0 Public DomainMany tiny organisms including bacteria, fungi and viruses
Gastroenterology January 24,2024
Low liver awareness among the public

Low liver awareness among the public

Low liver awareness among the publicbyKarolinska InstitutetGraphical abstract. Proportions of the general population that consider different diseases to carry social stigma. Credit:Clinics
Gastroenterology January 24,2024
Low liver awareness among the public

Low liver awareness among the public

Low liver awareness among the publicbyKarolinska InstitutetGraphical abstract. Proportions of the general population that consider different diseases to carry social stigma. Credit:Clinics
Gastroenterology January 24,2024
FDA issues warning on dangers of probiotic products for preemie babies

FDA issues warning on dangers of probiotic products for preemie babies

by Cara MurezFederal regulators have sent warning letters to two companies for illegally selling probiotic products for use in preterm infants.The U.S. Food and Drug Administration also sent a letter
Gastroenterology January 24,2024
FDA issues warning on dangers of probiotic products for preemie babies

FDA issues warning on dangers of probiotic products for preemie babies

by Cara MurezFederal regulators have sent warning letters to two companies for illegally selling probiotic products for use in preterm infants.The U.S. Food and Drug Administration also sent a letter
Gastroenterology January 24,2024
Changes in biochemical, hematological parameters seen before IBD diagnosis

Changes in biochemical, hematological parameters seen before IBD diagnosis

Changes in biochemical, hematological parameters seen before IBD diagnosisby Elana GotkineChanges in multiple biochemical and hematological parameters occur up to eight years before diagnosis of Crohn
Gastroenterology January 24,2024
Changes in biochemical, hematological parameters seen before IBD diagnosis

Changes in biochemical, hematological parameters seen before IBD diagnosis

Changes in biochemical, hematological parameters seen before IBD diagnosisby Elana GotkineChanges in multiple biochemical and hematological parameters occur up to eight years before diagnosis of Crohn
Gastroenterology January 24,2024
Genomic study on ulcers in European and Asian populations could lead to new population-specific treatments

Genomic study on ulcers in European and Asian populations could lead to new population-specific treatments

Genomic study on ulcers in European and Asian populations could lead to new population-specific treatmentsbyUniversity of TokyoPopulation variation. This chart shows how there are some outlying
Gastroenterology January 24,2024
Genomic study on ulcers in European and Asian populations could lead to new population-specific treatments

Genomic study on ulcers in European and Asian populations could lead to new population-specific treatments

Genomic study on ulcers in European and Asian populations could lead to new population-specific treatmentsbyUniversity of TokyoPopulation variation. This chart shows how there are some outlying
Gastroenterology January 24,2024
Gut microbiome variations could predict colorectal cancer risk, new study finds

Gut microbiome variations could predict colorectal cancer risk, new study finds

Gut microbiome variations could predict colorectal cancer risk, new study findsby United European GastroenterologyCredit: CC0 Public DomainNew research has identified significant variations in the gut
Gastroenterology January 24,2024
Gut microbiome variations could predict colorectal cancer risk, new study finds

Gut microbiome variations could predict colorectal cancer risk, new study finds

Gut microbiome variations could predict colorectal cancer risk, new study findsby United European GastroenterologyCredit: CC0 Public DomainNew research has identified significant variations in the gut
Gastroenterology January 24,2024
Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel disease

Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel disease

Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel diseaseby Higher Education Press7-DHC alleviated experimental colitis with circadian disruption. Cred
Gastroenterology January 24,2024
Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel disease

Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel disease

Gut microbiota-derived 7-DHC found to ameliorate circadian rhythm disorders and inflammatory bowel diseaseby Higher Education Press7-DHC alleviated experimental colitis with circadian disruption. Cred
Gastroenterology January 24,2024
Following one death, FDA warns hospitals about giving probiotics to preemies

Following one death, FDA warns hospitals about giving probiotics to preemies

by Cara MurezFederal regulators are cautioning doctors not to give probiotics to preterm infants.An infant given probiotics at an undisclosed hospital has died, U.S. Food and Drug Administration offic
Gastroenterology January 24,2024
Following one death, FDA warns hospitals about giving probiotics to preemies

Following one death, FDA warns hospitals about giving probiotics to preemies

by Cara MurezFederal regulators are cautioning doctors not to give probiotics to preterm infants.An infant given probiotics at an undisclosed hospital has died, U.S. Food and Drug Administration offic
Gastroenterology January 24,2024
How gut microbes help alleviate constipation

How gut microbes help alleviate constipation

How gut microbes help alleviate constipationbyCell PressCredit: CC0 Public DomainScientists have identified the genes in the probiotic Bifidobacteria longum responsible for improving gut motilit
Gastroenterology January 24,2024
How gut microbes help alleviate constipation

How gut microbes help alleviate constipation

How gut microbes help alleviate constipationbyCell PressCredit: CC0 Public DomainScientists have identified the genes in the probiotic Bifidobacteria longum responsible for improving gut motilit
Gastroenterology January 24,2024
Risk of serious infection even in low-active IBD, finds study

Risk of serious infection even in low-active IBD, finds study

Risk of serious infection even in low-active IBD, finds studyby Gustav Löfgren,Swedish Research CouncilRisk of serious infections in patients with histological inflammation vs histological remis
Gastroenterology January 24,2024
Risk of serious infection even in low-active IBD, finds study

Risk of serious infection even in low-active IBD, finds study

Risk of serious infection even in low-active IBD, finds studyby Gustav Löfgren,Swedish Research CouncilRisk of serious infections in patients with histological inflammation vs histological remis
Gastroenterology January 24,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com